Immune Modulation of Vascular Resident Cells by Axl Orchestrates Carotid Intima-Media Thickening  by Gerloff, Janice & Korshunov, Vyacheslav A.
The American Journal of Pathology, Vol. 180, No. 5, May 2012
Copyright © 2012 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
DOI: 10.1016/j.ajpath.2012.01.036Vascular Biology, Atherosclerosis, and Endothelium Biology
Immune Modulation of Vascular Resident Cells by
Axl Orchestrates Carotid Intima-Media ThickeningJanice Gerloff and Vyacheslav A. Korshunov
From the Department of Medicine, Aab Cardiovascular Research
Institute, University of Rochester School of Medicine and
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Cellular mechanisms of carotid intima-media thicken-
ing (IMT) are largely unknown. The receptor tyrosine
kinase Axl is essential for function of both bone mar-
row (BM) and non-BM cells. We studied the mecha-
nisms by which Axl expression in BM-derived cells
(compared with non-BM-derived cells) mediates ca-
rotid IMT. Partial ligation of the left carotid artery
resulted in a similar carotid blood flow reduction in
Axl chimeras. Neither irradiation nor bone marrow
transplantation had any effect on the 40% difference
in carotid IMT between Axl genotypes. Axl-dependent
survival is very important for intimal leukocytes;
however, Axl expression in BM cells contributes to
<30% of carotid IMT. Axl in non-BM cells has a
greater effect on carotid remodeling. Expression of
Axl in non-BM cells is crucial for the up-regulation of
several key proinflammatory signals (eg, IL-1) in the
carotid. We found that Axl is involved in immune acti-
vation of cultured smooth muscle cells and in immune
heterogeneity of medial cells (measured by major his-
tocompatibility complex class II) after carotid injury.
Finally, a lack of Axl in non-BM cells increased collagen
I expression, which may play a critical role in carotid
remodeling. Our data suggest that Axl contributes to
carotid remodeling not only by inhibition of apoptosis
but also via regulation of immune heterogeneity of vas-
cular cells, cytokine/chemokine expression, and extra-
cellular matrix remodeling. (Am J Pathol 2012, 180:
2134–2143; DOI: 10.1016/j.ajpath.2012.01.036)
Risks of heart disease and stroke are associated with
increase in carotid intima-media thickening (IMT) in hu-
mans.1 However, the cellular mechanisms of carotid IMT
are largely unknown. Although it is well accepted that
non-bone marrow (non-BM) cells play a central role in
intima formation,2 recent studies in atherosclerotic mice
showed that intimal cells are derived from multiple origins
2134and are immunologically heterogeneous.3 Immune heter-
ogeneity of endothelial, smooth muscle, and immune
cells was documented by expression of major histocom-
patibility complex class II (MHC II) in the carotid neoin-
tima after balloon injury in rats.4
The TAM (Tyro3, Axl, and Mertk) family of receptor
tyrosine kinases controls various cell functions.5 Two li-
gands activate TAM receptors: growth arrest-specific
protein 6 (Gas6) and protein S.6 TAM receptors control
survival and phagocytosis, as well as production of pro-
inflammatory cytokines in innate immune cells.7 Recent
data suggest that Gas6/TAM-dependent immune re-
sponses involve interactions among multiple cell types,
including vascular and immune cells, in cancer develop-
ment.8,9 The Gas6/Axl pathway is involved in pathogen-
esis of vascular diseases.10–14 In particular, Axl contrib-
utes to carotid IMT in response to low blood flow, and Axl
inhibited vascular apoptosis and affected vascular in-
flammation during carotid artery remodeling.11 Our goal
in the present study was to investigate the role of Axl
expressed in BM-derived and non-BM cells in carotid IMT
in response to low blood flow.
Materials and Methods
Animals
Male Axl knockout (Axl/) mice were obtained from our
colony. B6.SJL-PtprcaPep3b/BoyJ mice purchased from
the Jackson Laboratory (Bar Harbor, ME) were bred in
house. After confirming that the B6.SJL-PtprcaPep3b/
BoyJ (CD45.1) mice expressed the Axl gene [with Axl
wild-type (Axl/) littermates from our colony taken as the
standard; see Supplemental Figure S1 at http://ajp.
amjpathol.org], we used these B6.SJL-PtprcaPep3b/BoyJ
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isolation from tails and genotyping were performed as
described previously.11 All experiments were approved
by the University of Rochester Animal Care Committee
and were conducted in accordance with the NIH Guide
for the Care and Use of Laboratory Animals and with
American Heart Association guidelines (8th edition).
Primary Vascular Cell Culture
We established primary mouse aortic smooth muscle cell
(MASMC) lines from Axl mice, as described previously.15
There were no differences in cell growth between
MASMCs harvested from Axl/ and Axl/ mice (data
not shown). Mouse interferon- (IFN-; 1000 U/mL; 24
hours) was used to stimulate major histocompatibility
complex class II (MHC II) expression (measured by rel-
ative expression of the mouse H2-Ab1 gene) in Axl
MASMCs at passage 4, as described previously for hu-
man vascular smooth muscle cells (VSMCs).16 Control
MASMCs were treated with PBS for 24 hours. mRNAs
isolated from MASMCs and quantitative RT-PCR were
assayed for mouse Axl, H2-Ab1, and GAPDH as de-
scribed previously.17
Bone Marrow Transplantation
For detection of BM cells, we used a naturally occurring
allelic variant of transmembrane CD45 glycoprotein in BM
transplantation (BMT). The more common CD45.2 allele is
carried by C57BL/6mice, which is the background strain for
our Axl/ colony (CD45.2). The CD45.1 allele is carried
by B6.SJL-PtprcaPep3b/BoyJ mice (also on a C57BL/6
background). We used 5- to 7-week-old male mice for BMT.
Briefly, BM cells were harvested from tibias and femurs of
age-matched Axl/ or Axl/ donor mice. Before BMT,
recipient mice were irradiated (9.0 Gy) to ablate the host
BM, using an RS2000 irradiator (Rad Source Technologies,
Suwanee, GA). Recipient mice were injected with 6  106
donor BM cells via tail vein.
Flow Cytometry
Blood collection was done by the submandibular bleed-
ing method without anesthesia. The ACK erythrocyte lys-
ing buffer (Invitrogen, Carlsbad, CA) was used to lyse red
blood cells. Flow cytometry analyses were performed
using a six-color FACSCanto II system (BD Biosci-
ences, San Jose, CA) and FlowJo software version
7.6.3 (Tree Star, Ashland, OR). The engraftment of the
recipient BM was confirmed by analyses of the periph-
eral blood stained with a cocktail of CD45.1-fluorescein
isothiocyanate and CD45.2-phycoerythrin antibodies
(1:500; eBioscience, San Diego, CA) 6 weeks after
injections.18
Carotid Artery Ligation
Upon successful BM repopulation, Axl chimeras were
anesthetized with injection of ketamine (130 mg/kg i.p.)and xylazine (8.8 mg/kg i.p.) in saline (10 mL/kg) and
maintained at 37°C on a heating pad. Reduction of blood
flow in the left common carotid artery was achieved by
ligation of external and internal branches as described
previously.19 We administered flunixin (Banamine; 2.5
mg/kg, i.p.) preoperatively, and then again 24 hours
later if needed to alleviate discomfort. The Axl chimeras
were allowed to recover and were housed individually
under specific-pathogen-free conditions with 12/12
hours light/dark cycle for 2 weeks after the surgery. An
ultrasonic transit-time volume flowmeter (Transonic
Systems, Ithaca, NY) was used to measure common
carotid blood flow, as described previously.19
Morphometry and Immunohistochemistry
For euthanasia, all animals were anesthetized with injec-
tion of ketamine (130 mg/kg i.p.) and xylazine (8.8 mg/kg
i.p.). Tissues were perfusion fixed with 10% paraformal-
dehyde in sodium phosphate buffer (pH 7.0), as de-
scribed previously.19 Tissue processing, staining with
H&E (Dako, Carpinteria, CA), and morphometry analyses
(MCID image software version 6.0; Imaging Research-GE
Healthcare Niagara, St. Catherine’s, ON, Canada) of the
10 sections every 200 m from carotid bifurcation were
performed as described previously.19 Variations in ca-
rotid intimamedia (or media) and adventitia areas were
greater over a length of 2 mm in the ligated left carotid
artery (LCA), compared with the contralateral right ca-
rotid artery (RCA) among Axl chimeras (see Supplemen-
tal Figures S2, B and C, and S3, B and C, at http://
ajp.amjpathol.org). The compartment volumes were
calculated based on lumen, intima, media, adventitia,
and the external elastic lamina areas over the 1600-m
length of the carotid artery.19
Carotid cross-sections taken 1 mm proximal from
carotid bifurcation from Axl chimeras were double-
stained with biotinylated CD45.1 (1:100) and CD45.2 (1:
100) antibodies (BD Pharmingen, San Diego, CA) with
methyl green (Dako) counterstain. MHC II (OX6) antibody
or collagen I (Col I) were counterstained with hematox-
ylin, as described previously.4,20 A high temperature
(120°C) was used for antigen retrieval with Decloaker
solution (pH 6.0; Biocare Medical, Concord, CA) for 25
minutes for CD45.1/CD45.2. Primary antibodies were
subsequently incubated at 37°C for 60 minutes, followed
by incubation with polymer MM-HRP (CD45.1) and
polymer MM-AP (CD45.2) for 20 minutes each (MM kits;
Biocare Medical). The peroxidase-binding sites
(CD45.1, MHC II, and Col I) were verified with 3,3=-
diaminobenzidine (Dako). The alkaline-phosphatase-
binding sites (CD45.2) were validated by the Fast Red
method (Vulcan Fast Red; Biocare Medical). For DNA
fragmentation of apoptotic cells we used a Chemicon
ApopTag peroxidase in situ apoptosis detection kit (Mil-
lipore Bioscience Research Reagents, Temecula, CA)
with methyl green counterstain.11 Vascular calcification
was determined by staining carotids with Alizarin Red S
with fast green counterstain. Images of immunoassayed
carotid sections were captured at various magnifications
(20 to 60) with a SPOT Insight camera (Spot Imaging
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mounted on an Olympus BX41 microscope. We uniformly
adjusted size and contrast of the images to meet journal
guidelines (Adobe Photoshop CS3 version 10.0.1). Anal-
yses of relative expression of the antigens in three to five
mice (two to three sections/mouse) were performed using
ImagePro software version 6.2.21
Quantitative RT-PCR
In a separate set of Axl chimeras (n  3 per group of 4),
carotids were harvested 2 weeks after the surgery and
immediately frozen in liquid nitrogen as described previ-
ously.17 Vascular RNA was isolated with a Qiagen (Va-
lencia, CA) RNeasy micro kit, and amplified cDNA was
isolated with a NuGEN (San Carlos, CA) Ovation RNA
amplification system V2.17 We assayed cDNA samples
using an SABiosciences mouse inflammatory cytokines
and receptors PCR Array (PAMM-011; Qiagen, Valencia,
CA). Expression of the three housekeeping genes [-
glucuronidase (Gusb), hypoxanthine guanine phosphori-
bosyl transferase 1 (Hprt), and -actin (Actb)] was the
same across Axl mice. Therefore we chose these genes
for normalization performed with an Excel-based tem-
plate file from SABiosciences (Qiagen). We performed
bioinformatics analyses of transregulation of transcription
factors based on gene expression profiles from carotids
across Axl chimeras, using the curated InnateDB re-
A
0% 97%
94% 2%
C
D
45
.1
-F
IT
C
CD45.2-PE
99% 0%
4% 96%
B
C D
Figure 1. Flow cytometry analyses of peripheral blood from Axl chimeras.
A–D: Representative CD45.1/CD45.2 double staining of peripheral blood
from chimeras Axl/¡ Axl/ (A) Axl/¡ Axl/ (B), Axl/¡ Axl/
(C), and Axl/¡ Axl/ (D). CD45.1 cells are Axl/; CD45.2 cells are
Axl/. Percentages in the upper-left and lower-right quadrants indicate
extent of engraftment 6 weeks after BMT in Axl chimeras. FITC, fluorescein
isothiocyanate; PE, phycoerythrin.source (http://www.innatedb.ca).Statistical Analysis
Data are expressed as means SEM. We used JMP5.1.2
software (SAS Institute, Cary, NC) for statistical tests,
except for multiple quantitative RT-PCRs. One-way anal-
ysis of variance with repeated measurements was used
to evaluate differences among the morphometry data of
carotids from Axl chimeras. Relative expression of immu-
noreactive markers was analyzed by nonparametric Wil-
coxon test across Axl chimeras. Quantitative RT-PCR gene
expression differences between two groups were analyzed
by the Student’s t-test. Analyses of the PCR arrays were
done in three steps, using an Excel-based template from
SABiosciences (Qiagen). First, the template automatically
performed all CT-based fold-change calculations from the
uploaded raw threshold cycle data. Second, it executed
pairwise comparison between two groups of experimental
replicates and defined fold-change and statistical signifi-
cance thresholds. Finally, the obtained gene expression
results were presented as dots on volcano plots with posi-
tive and negative cutoffs and P  0.05 indicated. The level
of P  0.05 was considered significant.
Results
Bone Marrow Transplantation between Axl
Genotypes
To directly address the role for Axl-derived BM cells on
vascular remodeling, we created Axl chimeras by BMT.
Representative flow cytometry charts show a repopula-
tion of the BM in four groups of Axl chimeras 6 weeks after
BMT (Figure 1). As expected, control chimeras [Axl/¡
Axl/ (CD45.1) versus Axl/ ¡ Axl/ (CD45.2)]
exhibited nearly 100% replacement of the donor BM (Fig-
ure 1, A and B). We successfully generated Axl chimeras
with replaced peripheral blood cells of the opposite ge-
notype (Figure 1, C versus A and D versus B). We con-
cluded that engraftment in Axl chimeras is appropriate to
study the relative contribution of BM and non-BM cells to
vascular remodeling.
Carotid Remodeling in Axl Chimeras
The ligation procedure resulted in very similar carotid
blood flow reduction in the common LCA across Axl chi-
meras (Table 1). The Axl/ ¡ Axl/ chimeras had
Table 1. Blood Flow in the Common Carotid Artery in Axl
Chimera Mice after Ligation
Chimera*
Blood flow (mL/min)
LCA RCA
Axl/ ¡ Axl/ 0.07  0.03† 0.98  0.07
Axl/ ¡ Axl/ 0.05  0.02† 1.05  0.10
Axl/ ¡ Axl/ 0.06  0.01† 1.04  0.05
Axl/ ¡ Axl/ 0.07  0.02† 1.03  0.06
*n  3 mice/chimera.
†P  0.05 versus RCA blood flow (Student’s t-test).
LCA, left carotid artery; RCA, right carotid artery.
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chimeras (Figure 2, A and B). These findings are in
agreement with our original observations in Axl littermates
without BMT.11 The RCA media volume was the same
across Axl chimeras, but the LCA intimamedia volume
was lower in Axl/, compared with Axl/ mice (Figure
2D). Relative changes in intimamedia between chime-
ras of Axl genotypes were similar to those in Axl litter-
mates.11 Expression of Axl in BM cells did not increase
LCA intimamedia volume in Axl/ ¡ Axl/ chime-
ras, compared with Axl/ ¡ Axl/ (Figure 2D). How-
ever, Axl depletion in BM-derived cells in Axl/ ¡
Axl/ chimeras resulted in a 25% reduction in
intimamedia, compared with the Axl/ ¡ Axl/
group (Figure 2D). The only Axl/ non-BM chimeras
exhibited small reduction of RCA lumen and adventitia
of both carotid volumes (Figure 2, C and E). The size of
the ligated carotid (measured by external elastic lam-
ina volume) was significantly smaller in chimeras lack-
ing Axl in BM, non-BM, or both cell lineages, compared
with Axl/¡ Axl/ mice (Figure 2F). Taken together,
Axl deficiency in non-BM-derived cells had a much
greater effect on flow-induced carotid remodeling than
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Figure 2. Flow-induced carotid remodeling in Axl chimeras. A and B:
Photomicrographs of the left carotid artery (LCA) cross-sections from Axl
chimeras 2 weeks after ligation: Axl/ ¡ Axl/ (inset: Axl/ ¡
Axl/) (A) and Axl/ ¡ Axl/ (inset: Axl/ ¡ Axl/) (B). Brack-
ets span the area between internal and external elastic lamina. Open
boxes indicate intima formation; gray boxes indicate adventitia. Original
magnification, 20. Scale bar  100 m. C–F: Vessel component vol-
umes: lumen (C), intimamedia (D), adventitia (E), and external elastic
lamina (F). Axl chimeras are shown on the x axis. Axl/ ¡ Axl/, n  5;
Axl/¡ Axl/, n  5; Axl/¡ Axl/, n  7; Axl/¡ Axl/, n  7.
Data are expressed as means  SEM. *P  0.05 versus Axl/¡ Axl/; †P 
0.05 versus Axl/¡ Axl/.in BM-derived cells.Carotid Leukocytes in Axl Chimeras
We were able to distinguish BM-derived cells in the
carotid arteries after ligation across Axl chimeras using
immunohistochemistry (Figure 3). The majority of the
CD45 cells were localized to the intima and adventitia
(Figure 3, A and B). We recapitulated previous obser-
vations of higher levels of CD45.2 cells in the intima
from Axl/ mice, compared with CD45.1 cells in
Axl/ mice (Figure 3, A and B). Less than 0.05% of
host CD45.1 cells were detected in the intima of chi-
meras with Axl/ in BM cells (Figure 3E). However,
there were no detectable CD45.2 (Axl/) cells in the
intima of carotids from Axl/ ¡ Axl/ chimeras (Fig-
ure 3E). Thus, the Axl genotype of intimal leukocytes
reflected CD45 expression in peripheral blood from Axl
chimeras (Figure 1).
Carotid Apoptosis in Axl Chimeras
More apoptotic cells were observed in the intima than in
the media in ligated carotids from Axl/ ¡ Axl/ mice
(Figure 3, C and D). Intimal apoptosis was five times
greater in Axl/ chimeras, compared with Axl/ chime-
ras (Figure 3F). Axl expression in BM-derived cells sig-
nificantly reduced apoptosis in the intima, compared with
Axl/ ¡ Axl/ mice (Figure 3, D and F). Conversely,
deletion of Axl in BM cells increased apoptosis in the
intima, compared with the Axl/¡ Axl/ group (Figure
3, D and F). The Gas6/Axl pathway has been shown to
increase survival and protected smooth muscle cells
from calcium deposition in vitro.22 However, we found no
evidence of calcification in the remodeled carotids from
Axl chimeras (see Supplemental Figure S4 at http://
ajp.amjpathol.org). Taken together, our data suggest that
Axl-dependent pathways are crucial for survival of intimal
leukocytes, but have a modest effect on carotid IMT
(Figure 2).
Cytokine and Chemokine Expression in Carotids
from Axl Chimeras
We evaluated expression of cytokines/chemokines and
their receptors, to gain insight into mechanisms by which
Axl in non-BM cells determines carotid IMT (Supplemen-
tal Tables S1–S3 at http://ajp.amjpathol.org). Five genes
were significantly down-regulated in the ligated carotids
with Axl depletion in both lineages (Figure 4A). In partic-
ular, reduced expression of interleukin-1 (Il-1), inter-
leukin-1 receptor type 1 (Il1r), C-C motif chemokine 3
(Ccl3), and the C-X-C motif chemokines 1 and 5 (Cxcl1
and Cxcl5) was evident in carotids from Axl/ mice.
Even though carotid IMT was slightly reduced in chime-
ras with deleted Axl in BM cells, all five genes were
expressed at lower levels (Figure 4B). However, one
chemokine receptor (Ccr10) was up-regulated and eight
more genes were down-regulated in chimeras with Axl/
in BM cells. Depletion of Axl in non-BM cells resulted in
even more genes being down-regulated (Figure 4C). In
chimeras that lack Axl in BM or non-BM cells, expression
of seven common genes (Ccl4, Ccl6, Ccl9, Ccr5, Itgam,
Axl+/+
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AJP May 2012, Vol. 180, No. 5Il1b, and Pf4) was decreased in ligated carotids (Figure
4, B and C). These findings suggest that Axl expression
equally affects IL-1, chemokine, and integrin -M (Itgam)
signals by cells of both lineages during carotid remodel-
ing. Importantly, deficiency of Axl in non-BM cells further
decreased expression of five genes (Ccr1, Ccr3, C3,
Il1r2, and Tnfrsf1b), compared with Axl/ mice (Figure
4C). We found a very complex network of transcription
factors that transregulate target genes in our experiments
(see Supplemental Figure S5 at http://ajp.amjpathol.org).
However, the most common transcription factors (linked
to two to five target genes, including Foxa1, Aire, Sp1,
and Elk1) were very similar in chimeras with different
levels of expression of Axl. In contrast, a significant re-
duction of the complement component 3 (C3) gene may
suggest a reduced antigen-presenting cell (APC) activity
in chimeras with Axl/ in non-BM cells (Figure 4C). It
was documented23 that C3 knockout (C3/) mice ex-
hibited reduced stimulatory activity of APC and MHC II
50μm
50μm
Axl+/+ 
→Axl+/+
Axl-/-
→Axl+/+
Axl+/+ 
→Axl-/-
Axl-/-
→Axl-/-
Axl+/+ 
→Axl+/+
A
→
R
el
at
iv
e 
st
ai
ni
ng
 p
er
 a
re
a,
 %
R
el
at
iv
e 
st
ai
ni
ng
 p
er
 a
re
a,
 %
* *
*
† †
A B
C D
E Fexpression. Thus, we conclude that Axl expression iscritical for immune activation of non-BM cells and by
production of proinflammatory cytokines and chemokines
during carotid remodeling.
Axl-Dependent Immune Modulation of Vascular
Cells
We found that MASMCs harvested from Axl/ and
Axl/ mice grew at the same rate, whereas levels of Axl
were diminished in Axl/ cultured cells (data not
shown). Expression of MHC II was similar between un-
stimulated MASMCs from both Axl genotypes (Figure 5).
Intensity of MHC II was dramatically increased in outer
medial layer in chimeras that express Axl in non-BM cells
only (Axl/ ¡ Axl/; Figure 6A). However, a dramatic
up-regulation of MHC II was significantly attenuated in
Axl/, compared with Axl/ MASMCs after IFN- treat-
*
Axl+/+ 
→Axl-/-
Axl-/-
→Axl-/-
†
Figure 3. Immunohistochemical evaluation of
intimal leukocytes and apoptosis in carotids
from Axl chimeras. A and B: Representative
CD45.1/CD45.2 double staining of carotids:
Axl/¡ Axl/ (inset: Axl/¡ Axl/) (A)
and Axl/¡ Axl/ (inset: Axl/¡ Axl/)
(B). CD45.1 (Axl/) cells staining dark brown
(black arrows); CD45.2 (Axl/) cells stain
red (red arrows). C and D: Representative Apo-
ptag staining of carotids: Axl/ ¡ Axl/ (in-
set: Axl/¡ Axl/) (C) and Axl/¡ Axl/
(inset: Axl/ ¡ Axl/) (D). Apoptotic cells
stain dark brown (open arrows). Brackets
span the area between internal and external elastic
laminae. Original magnification, 60. Scale bar 
50 m. E: Relative intimal leukocyte staining for
CD45.1, and CD45.2 cells. Axl/ ¡ Axl/,
n 5; Axl/¡ Axl/, n 4; Axl/¡ Axl/,
n 4; Axl/¡ Axl/, n 4. F: Relative intimal
apoptosis staining Axl/ ¡ Axl/, n  3;
Axl/¡ Axl/, n  3; Axl/¡ Axl/, n 
3; Axl/¡ Axl/, n 3. Data are expressed as
means SEM. *P 0.05 versus Axl/¡ Axl/;
†P  0.05 versus Axl/¡ Axl/.*
xl-/-ment (Figure 5). Moreover, ligation slightly increased MHC
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AJP May 2012, Vol. 180, No. 5II in the media of Axl/ ¡ Axl/, but not in Axl/ ¡
Axl/ chimeras (Figure 6B). Increase in MHC II has been
correlated with reduction of Col I expression in smooth
Figure 4. Cytokine and chemokine gene profiling in carotids from Axl
chimeras. A–C: Effects of Axl deletion in both BM and non-BM lineages (A),
in BM cells (B), and in non-BM cells (C). Individual genes are represented as
dots on the volcano plots, in which log2-transformed fold changes in gene
expression are plotted against P values. Vertical lines indicate zero and both
positive and negative cutoffs; the horizontal line indicates the significance
level (P  0.05). Genes listed to the left of the zero line (negative values) are
down-regulated; those to the right (positive values) are up-regulated. Groups
of genes indicated by type style (black, gray, or italic) are as discussed in the
text. Expression data were obtained from three carotids per group.muscle cells.24 Similarly, Col I was significantly increasedin carotids from chimeras with deletion of Axl in non-BM
cells and coincided with the absence of MHC II immuno-
reactivity (Figure 6, C and D). Increased expression of
Col I in the intima-media (Figure 6, C and D) predicted
lower values of carotid IMT (Figure 2D). In addition, ad-
ventitial deposition of Col I (Figure 6, C and D) correlated
with reduced external elastic lamina in Axl chimeras (Fig-
ure 2F). In summary, we found that Axl expression in
non-BM cells controls MHC II, which determines the
extent of the carotid intima-media thickening via regu-
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Figure 5. Immune modulation of vascular cells by Axl cultured MASMCs.
Relative expression of the MHC II gene H2-Ab1 in Axl MASMCs in vitro.
Wild-type (Axl/) or knockout (Axl/) cells were treated with PBS or
IFN-. Axl/, n  3; Axl/, n  3. Data are expressed as means  SEM.
*P  0.05 versus Axl/.
Figure 6. Immune modulation and collagen expression in carotids from Axl
chimeras. A and B: Representative MHC II staining: Axl/¡ Axl/ (inset:
Axl/¡ Axl/) (A) and Axl/¡ Axl/ (inset: Axl/¡ Axl/) (B).
C and D: Representative Col I staining: Axl/ ¡ Axl/ (inset: Axl/ ¡
Axl/) (C) and Axl/ ¡ Axl/ (inset: Axl/ ¡ Axl/) (D). MHC II
cells (dark brown) are indicated by black arrows and Col I cells (dark
brown) are indicated by open arrows. A bracket spans the area between
internal and external elastic lamina. Original magnification, 60. Scale bar 
50 m.
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cellular matrix.
Discussion
The present findings provide new insights into mech-
anisms by which Axl contributes to vascular remodel-
ing (Figure 7). First, Axl-dependent survival is very
important for intimal leukocytes. However, Axl-depen-
dent signals in BM-derived cells may explain 30% of
carotid IMT. Second, Axl in non-BM cells has a much
greater effect on carotid remodeling. Third, we found
that Axl regulates immune heterogeneity of medial
cells (measured by MHC II), which directs carotid IMT;
we show, for the first time, that lack of Axl reduced
activation of MHC II in cultured smooth muscle cells in
response to IFN-. Fourth, depletion of Axl in non-BM
cells caused a greater down-regulation of several key
cytokine/chemokine signals (eg, IL-1) via a complex
network of transcription factors in carotids. Finally, ab-
sence of Axl in non-BM cells increased expression of
Col I and reduced carotid IMT. Taken together, our
findings suggest that Axl contributes to carotid remod-
eling via regulation of immune heterogeneity of vascu-
lar cells, cytokine/chemokine expression, and extracel-
lular matrix remodeling, in addition to the known
function of Axl in survival (Figure 7).
Our data from Axl chimeras are in agreement with a
major role for non-BM cells on vascular remodeling (Fig-
ure 2D). Most current efforts are focused on the origin of
the intimal cells.2 However, recent findings in experimen-
tal atherosclerosis suggest that intimal smooth muscle
cells are derived from multiple origins and exhibit im-
mune heterogeneity.3 Notably, some subsets of endothe-
lial cells, immune cells, and VSMCs expressed high lev-
els of MHC II in the neointima in later phases after balloon
injury in rats.4 We found significant compensation of MHC
Intim
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MHC IIEELII in the outer layer of carotid media in chimeras with Axlexpressed in non-BM cells only (Figure 6A). This unique
position of MHC II cells in the remodeled arterial wall
may allow interactions with progenitor cells from multiple
origins. This may also suggest that immune activation of
non-BM cells is crucial for later phases in response to
injury, as recently proposed.25 Likewise, Axl was up-
regulated during later phases of neointimal proliferation
in a rat balloon injury model.10
The most plausible mechanism for Axl in non-BM cells
is triggering of the PI3K/Akt pathway.26 Activation of the
PI3K/Akt pathway (by depletion of an inhibitor, PTEN)
resulted in increased production of the chemokine Cxcl1
in murine VSMCs and enhanced intima formation.27 We
also showed that Axl is responsible for up-regulation of
Cxcl1 in response to low flow (Figure 4). A critical role for
Axl in immune activation of VSMCs (by antigen presen-
tation) is supported by significant reduction of C3 in ca-
rotids from chimeras with Axl/ in non-BM cells (Figure
4C). A reduction of APC activity and MHC II was docu-
mented in C3/ mice.23 IFN- is a powerful stimulator of
MHC II in human VSMCs.16 However, the molecular
mechanisms of MHC II up-regulation are incompletely
understood. Activation of the PI3K/Akt/mTOR pathway
has been implicated in IFN- signal transduction.28 In
addition, immune heterogeneity of resident vascular cell
(MHC II positivity) might be related to down-regulation of
Col I expression.24 Specifically, immune activation of
smooth muscle cells up-regulated expression of major
histocompatibility class II transactivator (CIITA) that in-
creased MHC II gene expression and reduced Col I
expression in vitro. However, we found no effect of Axl on
CIITA in MASMCs (data not shown). Changes in extra-
cellular matrix are very important for cell function (eg,
migration) during vascular remodeling. Collagen deposi-
tion preceded inward remodeling after balloon injury,
possibly via stabilization of the vessel wall.29 Our findings
in chimeras suggest that lack of Axl in non-BM cells
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Figure 7. Mechanisms by which Axl regulates
carotid intima-media thickening, with known ef-
fects of Axl on survival during carotid intima-
media thickening (blue) and new mechanisms
of Axl-dependent immune activation of non-BM
cells, cytokine/chemokine expression, and inhi-
bition of Col I expression in the remodeled ca-
rotids (orange). Synthetic VSMCs are indicated
in purple; contractile VSMCs are indicated in
red. BM, bone marrow; Col I, collagen I; EEL,
external elastic lamina; IEL, internal elastic lam-
ina; MHC II, major histocompatibility complex
class II; VSMC, vascular smooth muscle cell.a-M
k
-
d 
c e
Cyto
Chem
C loshifted the balance toward more Col I over MHC II ex-
Immune Regulation of Carotid IMT by Axl 2141
AJP May 2012, Vol. 180, No. 5pression, which reduced carotid remodeling (Figure 6).
Future studies are required for dissection of the molecu-
lar mechanisms of MHC II activation by Axl in smooth
muscle cells.
We found that Axl-dependent pathways are most cru-
cial for survival of the BM cells in the intima (Figure 3).
Notably, apoptotic cells were positive in the intimal and
the inner layer of the media of carotids from chimeras with
Axl/ in non-BM cells, whereas the outer medial layer
was MHC II (Figures 4C and 6A). Increases in apoptosis
of VSMCs (by induction of human diphtheria toxin recep-
tor) dramatically enhanced atherosclerosis by intimal in-
flammation, medial degradation, and calcification in
proatherogenic (Apoe/) mice.30,31 Experimental data
in two mouse models of atherosclerosis (ApoE/ and
Ldlr/) suggest that a clearance of apoptotic cells relies
on Mertk.12,13 Lack of Mertk in BM and non-BM cells
accelerated atherosclerotic lesions, because of exces-
sive necrosis. However, subsets of innate immune cells
can use different TAM receptors for the clearance of
apoptotic cells.32 In contrast to Mertk, loss of Gas6 had
no effect on atherosclerotic plaque size, but dramatically
changed composition of the plaque in Apoe/ mice.14
Similarly, we found that only deletion of Axl in both lin-
eages increased intimal leukocytes (Figure 3E). A rela-
tively small human genetic study attempted to evaluate
association of the GAS6 and TAM polymorphisms with
carotid atherosclerosis.33 The authors reported a very
weak relationship between carotid atherosclerosis and
GAS6 or AXL variants, which was contradictory to their
previous reports on associations between GAS6 and
stroke.34–36 Future experiments will be required to deter-
mine roles for AXL in atherosclerotic plaque composition
and size in human and animal models.
TAM receptors regulate survival and phagocytosis of
innate immune cells.37 In addition, triple-TAM knockout
mice exhibited lymphoproliferative abnormalities, be-
cause of increased expression of proinflammatory cyto-
kines by activated macrophages. However, this autoim-
munity phenotype could be due to Mertk deficiency in
leukocytes.38 Gas6/TAM-mediated immune responses
require interactions between multiple cell types, includ-
ing vascular and immune cells.8 These cell-to-cell inter-
actions are responsible for neovascularization and tumor-
igenesis in breast cancer and are controlled by Axl.39
Recent studies in the CT26 model of colon cancer9
showed that this type of tumor growth progresses via
production of the Axl ligand, Gas6, by infiltrating leuko-
cytes. Our results in flow-induced carotid remodeling fur-
ther emphasize a key role for Axl-dependent pathways
for interactions between multiple cell lineages via pro-
duction of proinflammatory cytokines and chemokines.
The IL-1 receptor type I knockout (Il1r1/) mice reduced
intima formation in response to complete ligation.40 We
can speculate that expression of Axl in both lineages is
required for immune activation, even though the extent of
reduction in blood flow was different in experiments on
Il1r1/ (100%) mice,40 compared with our studies
(90%) in Axl chimeras. Recent microarray analyses dis-
covered number of mechanosensitive genes in a similar
mouse model of flow-dependent carotid remodeling.41Authors found significant over-representation of the im-
mune pathways with up-regulation of three genes (Ccl4,
Ccr5, and Spp1) that are controlled by Axl during carotid
IMT (Figure 4). Notably, integrin  subunits (Itgb2, Itgb4,
and Itgb7) are highly regulated in the carotid intima early
after flow reduction.41 We found that deletion of Axl in
either lineage significantly reduced expression of Itgam
in the carotid artery (Figure 4, B and C). Intima prolifera-
tion and leukocyte recruitment to the carotid were atten-
uated in Mac-1 (Itgam) knockout mice after mechanical
injury.42 Therefore, increases in intimal leukocytes in
Axl/ ¡ Axl/ chimeras may be explained, in part,
through regulation of Itgam.
There are three potential limitations of the present
study. First, a background mouse strain (C57BL/6) of
Axl chimeras exhibits significant but relatively small
carotid IMT, compared with other inbred strains.43 De-
spite this disadvantage of the background, we were
able to show that Axl expressed in non-BM cells was
responsible for carotid IMT (Figure 2). A second limi-
tation is related to the Axl-mediated transcriptional reg-
ulation of cytokine/chemokine production in cell lin-
eages. At this point, we were unable to identify specific
transcription factor or factors regulated by Axl. Finally,
activation of Axl has been reported in endothelial cells
that are critical for survival.44,45 It is possible that Axl-
dependent signals in endothelial or other resident cell
types are important for carotid IMT. Nonetheless,
based on in vitro experiments using MASMCs and MHC
II expression patterns in the ligated carotids from Axl
chimeras, it is likely that smooth muscle cells deter-
mine IMT (Figures 5 and 6).
In the present study, we identified a new mechanism
by which residential wall cells orchestrate carotid remod-
eling by activation of Axl (Figure 7). In particular, for the
first time we show that Axl regulates immune heteroge-
neity of non-BM cells and extracellular matrix reorganiza-
tion in the remodeled artery. We also identified several
key cytokine and chemokine pathways, which are depen-
dent on Axl during carotid IMT. Finally, Axl-dependent
signaling protects intimal leukocytes against apoptosis.
However, these prosurvival effects of Axl in BM-derived
cells contribute to 30% of carotid IMT. Our findings
provide new insights into immune modifications of vas-
cular resident cells, by which Axl controls vascular re-
modeling.
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